FDAnews Drug Daily Bulletin

Takeda Slaps Hetero With Lawsuit Blocking Its Generic Actos

Dec. 14, 2011
A A
Takeda Pharmaceuticals is suing Hetero Drugs and two subsidiaries to bar them from marketing generic versions of Type 2 diabetes drug Actos.
Generic Line